repaglinide has been researched along with Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burgos, DF; Dopazo, XM; González, P; González, V; López-Hurtado, A; Mellström, B; Naranjo, JR; Rábano, A | 1 |
| Arrabal, MD; Casado-Vela, J; Cercós, P; De la Cruz, A; Dopazo, XM; González, P; González, T; Gutierrez-Rodriguez, M; Higueras, E; Li, JY; Mellström, B; Morón-Oset, J; Naranjo, JR; Oliveros, JC; Prieto, A; Rábano, A; Valenzuela, C; Villar, D; Zhang, H | 1 |
2 other study(ies) available for repaglinide and Huntington Disease
| Article | Year |
|---|---|
Inhibition of DREAM-ATF6 interaction delays onset of cognition deficit in a mouse model of Huntington's disease.
Topics: Activating Transcription Factor 6; Animals; Carbamates; Cognition Disorders; Disease Models, Animal; Hippocampus; Humans; Huntington Disease; Kv Channel-Interacting Proteins; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Neuronal Calcium-Sensor Proteins; Neurons; Piperidines; Rotarod Performance Test | 2018 |
Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease.
Topics: Activating Transcription Factor 6; Animals; Carbamates; CHO Cells; Corpus Striatum; Cricetulus; Disease Models, Animal; HEK293 Cells; HeLa Cells; Humans; Huntington Disease; Kv Channel-Interacting Proteins; Mice; Neurons; Piperidines; Repressor Proteins; Signal Transduction | 2016 |